Lauren Gunasti

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Adrienne Luoma, Shengbao Suo, Yifan Wang et al. · Cell · 2022 · 371 citations · Full text

Life Sciences, Immunology, Oncology +16

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

Jonathan D. Schoenfeld, Anita Giobbie‐Hurder, Srinika Ranasinghe et al. · The Lancet Oncology · 2022 · 232 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade

Umair Mahmood, Mai Anh Huynh, Joseph H. Killoran et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 15 citations

Medicine, Oncology, Radiation Oncology +16

Use of Fluoro-[¹⁸F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers

Hina Shah, Yating Wang, Su–Chun Cheng et al. · JAMA Otolaryngology–Head & Neck Surgery · 2022 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors

Jack M. Qian, Elliot H. Akama‐Garren, Jungwook Shin et al. · Advances in Radiation Oncology · 2021 · 10 citations · Full text

Medicine, Oncology, Radiation Oncology +14